PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1391844
PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1391844
REPORT OVERVIEW
This report offers market size & forecast data for the global premature ejaculation therapeutics market. The revenue generated from the sale of drugs, including off-label products, is included in the report. The revenue generated from the devices used to manage premature ejaculation, physicians' fees, and other service-related costs is excluded from the report's scope. This report provides a comprehensive and current market scenario of the global premature ejaculation therapeutics market, including the global premature ejaculation therapeutics market size, anticipated market forecast, relevant market segmentations, and industry trends.
The study considers a detailed scenario of the present global premature ejaculation therapeutics market and its market dynamics for 2024-2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET DEFINITION
Premature ejaculation (PE) is a male sexual dysfunction characterized by the inability to delay ejaculation for more than a minute after penetration that leads to negative personal consequences, such as distress, frustration, and/or the avoidance of sexual intimacy. Premature ejaculation (PE) is a common sexual problem that affects about 20-30% of men in the sexually active age group leading to psychological stress and loss of self-esteem.
KEY HIGHLIGHTS
VENDORS LIST
REPORT HIGHLIGHTS
PRODUCT SEGMENTATION & FORECAST
Selective Serotonin Re-uptake Inhibitors (SSRIs)
Phosphodiesterase type 5 (PDE5) inhibitors
Anesthetic Agents
Others
Oral Therapeutics
Topical Therapeutics
Below 45 years
Above 45 years
MARKET STRUCTURE
APPENDIX
CHAPTER - 1: PE Therapeutics Market Overview
CHAPTER - 2: PE Therapeutics Market
CHAPTER - 3: PE Therapeutics Market Segmentation Data
CHAPTER - 4: Key Regions Overview
CHAPTER - 5: PE Therapeutics Market Prospects & Opportunities
CHAPTER - 6: PE Therapeutics Industry Overview
CHAPTER - 7: Appendix